Categories
Uncategorised

Appointment within the ENGIE Group

Anne-Laure de Chammard

Anne-Laure de Chammard has been appointed Director of Strategy for the ENGIE group, effective October 1st 2019. Anne-Laure will take over from Antoine de La Faire, who has been appointed CEO of ENGIE Solar.
She will report to Shankar Krishnamoorthy, Executive Vice President in charge of Strategy & Innovation, Industrial Development, Research & Technology, Procurement and of the supervision of the Business Unit Africa.

Previously, she served as President and Chief Executive Officer of Bureau Veritas Construction, a subsidiary of the Bureau Veritas group, and was a member of the French Government’s High Council on Construction and Energy Efficiency.

Anne-Laure de Chammard graduated from the Ecole Polytechnique and the Ecole Nationale des Ponts et Chaussées. She also holds a Master’s degree in Public Policy from the Harvard Kennedy School.

Anne-Laure started her career in the USA in 2008, as a strategy consultant with the Boston Consulting Group. She then joined the French Ministry of Sustainable Development and Energy in 2010, where she was in charge of awarding and supervising major infrastructure contracts (motorways, high-speed railways, etc.) within the framework of public-private partnerships. She joined the Bureau Veritas Group in 2014 as Regional Manager for Burgundy Picardy Champagne-Ardenne (France), before being appointed President and CEO of Bureau Veritas Construction in 2016.

Anne-Laure also sits on the Supervisory Board of Marseille – Provence Airport.

Categories
BEIS

Calculate your agricultural worker holiday entitlement

Categories
BEIS

Calculate your employee's statutory redundancy pay

[unable to retrieve full-text content]Employer calculator – calculate your employee’s statutory redundancy payment

Categories
BEIS

Press release: World's largest genetics project to tackle deadly diseases launches

The £200 million whole genome sequencing project is being created, forming a partnership of pharmaceutical firms and health experts which will examine and sequence the genetic code of 500,000 volunteers at the UK Biobank, based in Stockport.

Prime Minister Boris Johnson said:

Britain has a proud history of putting itself at the heart of international collaboration and discovery. Over 60 years ago, we saw the discovery of DNA in Cambridge by a team of international researchers and today we are going even further. Now we are bringing together experts from around the globe to work in the UK on the world’s largest genetics research project, set to help us better treat life-threatening illnesses and ultimately save lives.

Breakthroughs of this kind wouldn’t be possible without being open to the brightest and the best from across the globe to study and work in the UK. That’s why we’re unveiling a new route for international students to unlock their potential and start their careers in the UK.

Genomics research has the potential to create a genuinely predictive, more personalised healthcare system and the UK has a clear desire to seize the opportunities that research in this area offers, which is why the government has committed to carrying out five million analyses of DNA by 2024.

The new project aims to improve health through genetic research, improve the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses including cancer, heart diseases, diabetes, arthritis and dementia.

Business Secretary Andrea Leadsom said:

Today’s funding will support one of the world’s most ambitious gene sequencing programmes ever undertaken, reflecting the UK’s determination to remain at the forefront of scientific endeavour and progress.

Its results could transform the field of genetic repeated research – unlocking the causes of some of the most terrible diseases and how we can best tackle them. It will be a major step forward for individually tailored treatment plans, and will help us better understand why some people get certain diseases while others don’t.

Health and Social Care Secretary Matt Hancock said:

I am incredibly excited by the potential of genomics to change the way we think about disease and healthcare. In an ageing society with an increasing burden of chronic diseases, it is vital that we diagnose earlier, personalise treatment and where possible prevent diseases from occurring altogether.

This project will help unlock new treatments and grow our understanding of how genetics effects our risk of disease. It is one part of our world leading set of genomics programmes, including the NHS’ Genomics Medicine Service and the Accelerated Detection of Disease challenge, and shows that the UK is the go-to destination for genomics research and development.

The UK Biobank recruited 500,000 people aged between 40 and 69 years between 2006 and 2010 from across the country. They have provided blood, urine and saliva samples for future analysis, detailed information about themselves and agreed to have their health followed on an anonymous basis.

Much of the sequencing will be by experts at the Wellcome Sanger Institute, based in Cambridge, and the results will help the NHS treat patients better.

Through the Biobank research, industry can work with experts to create new treatments and preventative measures which will help those suffering from illnesses and may eventually reveal why some people develop diseases and others do not.

Funding for the genome project comes from a consortium formed by the government’s research and innovation agency, UK Research and Innovation (UKRI) with £50 million through the Industrial Strategy Challenge Fund, £50 million from the research organisation, Wellcome.

A further £100 million has come from four of the world’s leading biopharmaceutical and healthcare companies Amgen, AstraZeneca, GlaxoSmithKline (GSK) and Johnson & Johnson.

The samples will be sequenced in equal numbers at the Wellcome Sanger Institute in Cambridge and the deCOde site in Iceland, from the genome sequencing company, Illumina.

Notes to editors

This follows a shake-up of immigration rules announced by the Prime Minister in August to encourage the world’s top scientists to move to the UK. The government will set out plans in the autumn to significantly boost public R&D funding, provide greater long-term certainty to the scientific community, and accelerate our ambition to reach 2.4% of GDP.

The new immigration route enables international students who have successfully completed a course in any subject at undergraduate level or higher to work, or look for work, at any skill level, giving them valuable work experience at the start of their careers. There will be no cap on the number of students who can apply for the new graduate route.

Students who start courses in 2020/21 at undergraduate level or above will be able to benefit from the new route. Those on the route will be able to switch onto the skilled work route if they find a job which meets the skill requirement of the route.

The new route for international students builds on the already strong offer available, which is why university-sponsored visa applications are at record levels and over 450,000 international students are currently studying in the UK per year. This will boost the government’s plans to increase the number international students by 30% to 600,000 by 2030, as set out in its International Education Strategy.

The genome project builds on a £34 million pilot programme funded by the Medical Research Council (MRC) that saw the first 50,000 UK Biobank participants analysed. This pilot or Vanguard project refined the approach needed to complete this globally unique project. All data held by UK Biobank is anonymised and protected.

The addition of complete genetic information to the information held by UK Biobank is expected to reveal why some people develop particular diseases and others do not. It may also hold the key to more precise treatments for a range of conditions tailored to the genetic makeup of an individual and help predict and prevent life-changing diseases.

Through this research, industry will be able to work with experts to create new products and services which will help those suffering from illnesses.

The government funding forms part of the delivery of the Life Sciences Sector deals and the modern Industrial strategy and is funded through the wider £210 million Industrial Strategy Challenge Fund: Data to early diagnosis and precision medicine, administered by UKRI.

Sir Mark Walport, Chief Executive of UK Research and Innovation said

As one of the half million participants in UK BioBank, I’m very excited by the potential of the Whole Genome Sequencing Project, which will sequence the genetic code of everyone in UK BioBank to help develop novel and personalised forms of healthcare.

UK BioBank is globally unique in the depth and quality of the information that it contains about so many people in health and disease. Adding whole genome sequencing data to this will provide major opportunities to improve how we prevent, diagnose and treat the chronic conditions that afflict so many of us as we live longer lives.

Prof Sir John Bell, HMG’s Life Sciences Champion, said:

This genome sequencing project will provide exciting new insights into the causes of many major diseases.

It builds on 70 years of pioneering work in genetics research and exemplifies the creation of a whole new sector in Life Sciences that the UK Life Sciences Industrial Strategy has been developing. We do not know what the project will uncover but it is certain to be both novel and informative.

John Lepore, Senior Vice President, Research at GlaxoSmithKline (GSK) said:

This historic whole genome sequencing effort is a welcome asset for researchers and testament to the volunteers who believe in the power of data to advance science.

Genetically validated drug candidates are twice as likely to become registered novel medicines, and efforts like this bring us closer to developing transformational medicines that can significantly improve patient health and change lives.

AstraZeneca quote: Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, commented:

Whole genome sequencing on this scale is unprecedented, and through this collaboration we hope to unlock the potential of genomics to evolve our understanding of complex diseases such as cancer, heart disease and chronic kidney disease.

These new insights will guide our drug discovery programme and will help us bring innovative new precision medicines to patients who need them most urgently.

Richard Tillyer, PhD, Global Head, Discovery, Product Development & Supply, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, commented:

We are proud to participate in this ground-breaking initiative to generate genomics data from samples obtained through the generosity of citizens/people in the United Kingdom.

The insights gained from the analysis of this rich data set will guide our efforts to develop safe and effective therapies so that diseases aren’t just being treated, they are predicted, pre-empted and stopped in their tracks to help generations of people live their healthiest lives.

NB: Contract entered by Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson

David M. Reese, M.D., Executive Vice-President of Research and Development at Amgen said:

We are pleased to partner on a project with immense potential to advance public health.

This collaboration reflects our belief in the power of human genetics to transform medicine and the need for continued growth in the size and diversity of the data that can be mined for new discoveries for patients with serious life-threatening diseases.

Kari Stefansson, CEO of deCODE Genetics, a subsidiary of Amgen, said:

deCODE is taking human genetic research to a new level, applying the methods we pioneered in Iceland to lead a worldwide search for disease genes.

As drug development programs backed by genetics are twice as likely to succeed, the data sequenced and analyzed through this collaboration will be essential to help the broader scientific community identify and validate promising drug targets for some of the most challenging diseases patients face.

Sara Marshall, Head of Clinical Research and Physiological Sciences at Wellcome, said:

This exciting new project will help scientists and doctors develop new ways of preventing, diagnosing and treating a range of life changing diseases such as cancer and dementia.

By sequencing the genomes of the UK Biobank participants, the research community will have an unprecedented resource to gain new insights into human disease.

This work would not be possible without the generous support of the 500,000 participants of the UK Biobank who, without any direct benefit to themselves, have allowed their lives to be studied through blood tests, body scans and information from their medical records all in the hope that it will benefit others.

Sir Michael Rawlins, Chair of UK Biobank’s Board said:

We are delighted that government, charity and industry have come together to unleash the full potential of UK Biobank by supporting the sequencing of all the participants.

It is a tribute to the altruism of the half million people who agreed to be part of UK Biobank, and it recognises the valuable findings that have already emerged from the project. Scientists around the world will be eager to use these genetic data in imaginative ways to further improve the health of the public.

Paula Dowdy, Illumina’s Senior Vice President and General Manager, EMEA, said:

Illumina would like to thank the Biobank volunteers who have generated this invaluable resource over more than a decade.

We are proud to support the project through the use of whole genome sequencing technology and unlock the power of 450,000 genomes to deliver world-leading genetic data that could transform the lives of so many.

About UK BioBank

UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency. It has also had funding from the Welsh Government, British Heart Foundation, Cancer Research UK and Diabetes UK. UK Biobank is supported by the National Health Service (NHS). UK Biobank is open to bona fide researchers anywhere in the world, including those funded by academia and industry. The medical research project is a non-profit charity which had initial funding of about £62 million and a subsequent investment over the past 10 years of around £180 million.

About the Wellcome Sanger Institute

The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations. Its success is founded on the expertise and knowledge of its people and the Institute seeks to share its discoveries and techniques with the next generation of genomics scientists and researchers worldwide.

About UK Research and Innovation

UKRI works in partnership with universities, research organisations, businesses, charities, and government to create the best possible environment for research and innovation to flourish. We aim to maximise the contribution of each of our component parts, working individually and collectively. We work with our many partners to benefit everyone through knowledge, talent and ideas.

Operating across the whole of the UK with a combined budget of more than £7 billion, UKRI brings together the seven Research Councils, Innovate UK and Research England.

Categories
BEIS

News story: World's largest genetics research project to fight deadly diseases and offer new offer for international students

Prime Minister Boris Johnson has unveiled plans to transform how talented international students are able build successful careers in the UK through a new immigration route, as a new ground-breaking project in the fight against life-threatening illnesses launches.

International students make up half of all full-time post-graduate students in Science, Technology, Engineering and Maths (STEM) subjects. The new immigration route announced today (11 September 2019) will mean international graduates in any subject, including STEM, will be able to stay in the UK for two years to find work.

Students will need to have successfully completed a degree from a trusted UK university or higher education provider which has a proven track record in upholding immigration checks and other rules on studying in the UK.

This will build on government action to help recruit and retain the best and brightest global talent, but also open up opportunities for future breakthroughs in science, technology and research and other world-leading work that international talent brings to the UK.

One example of pioneering research and international collaboration in the UK is the world’s largest genetics project, the £200 million whole genome sequencing project of all volunteers in the UK Biobank, launching today.

The new project aims to improve the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses including cancer, heart diseases, diabetes, arthritis and dementia, through genetic research that can explain why some people develop these conditions and others do not. The partnership of pharmaceutical firms and health experts from the UK and abroad will examine and sequence the genetic code of 500,000 volunteers at the UK Biobank.

This sits alongside the work by Genomics England in partnership with NHS England on the 100,000 Genomes Project, which has seen around 25% of patients with rare diseases receive a diagnosis for the first time, and for some conditions a diagnosis rate as high as 60%.

Prime Minister Boris Johnson said:

Britain has a proud history of putting itself at the heart of international collaboration and discovery. Over sixty years ago, we saw the discovery of DNA in Cambridge by a team of international researchers and today we are going even further. Now we are bringing together experts from around the globe to work in the UK on the world’s largest genetics research project, set to help us better treat life-threatening illnesses and ultimately save lives.

Breakthroughs of this kind wouldn’t be possible without being open to the brightest and the best from across the globe to study and work in the UK. That’s why we’re unveiling a new route for international students to unlock their potential and start their careers in the UK.

Business Secretary Andrea Leadsom said:

Today’s funding will support one of the world’s most ambitious gene sequencing programmes ever undertaken, reflecting the UK’s determination to remain at the forefront of scientific endeavour and progress.

Its results could transform the field of genetic repeated research – unlocking the causes of some of the most terrible diseases and how we can best tackle them. It will be a major step forward for individually tailored treatment plans, and will help us better understand why some people get certain diseases while others don’t.

Home Secretary Priti Patel said:

The new Graduate Route will mean talented international students, whether in science and maths or technology and engineering, can study in the UK and then gain valuable work experience as they go on to build successful careers.

It demonstrates our global outlook and will ensure that we continue to attract the best and brightest.

Education Secretary Gavin Williamson said:

It is a testament to our world-leading universities that so many students from abroad want to study here. The important contribution international students make to our country and universities is both cultural and economic. Their presence benefits Britain, which is why we’ve increased the period of time these students can remain in the UK after their studies.

Our universities thrive on being open global institutions. Introducing the graduate route ensures our prestigious higher education sector will continue to attract the best talent from around the world to global Britain.

Health and Social Care Secretary Matt Hancock said:

I am incredibly excited by the potential of genomics to change the way we think about disease and healthcare. In an ageing society with an increasing burden of chronic diseases, it is vital that we diagnose earlier, personalise treatment and where possible prevent diseases from occurring altogether.

This project will help unlock new treatments and grow our understanding of how genetics effects our risk of disease. It is one part of our world leading set of genomics programmes, including the NHS’ Genomics Medicine Service and the Accelerated Detection of Disease challenge, and shows that the UK is the go-to destination for genomics research and development.

Alistair Jarvis, Chief Executive of Universities UK:

This is very positive news. Evidence shows that international students bring significant positive social outcomes to the UK as well as £26 billion in economic contributions, but for too long the lack of post-study work opportunities in the UK has put us at a competitive disadvantage in attracting those students.

The introduction of a two-year post-study work visa is something Universities UK has long campaigned for and we strongly welcome this policy change, which will put us back where we belong as a first choice study destination. Not only will a wide range of employers now have access to talented graduates from around the world, these students hold lifelong links in the UK.

Prof Sir John Bell, HMG’s Life Sciences Champion, said:

This genome sequencing project will provide exciting new insights into the causes of many major diseases. It builds on 70 years of pioneering work in genetics research and exemplifies the creation of a whole new sector in Life Sciences that the UK Life Sciences Industrial Strategy has been developing. We do not know what the project will uncover but it is certain to be both novel and informative.

Sir Mark Walport, Chief Executive of UK Research and Innovation said:

As one of the half million participants in UK BioBank, I’m very excited by the potential of the Whole Genome Sequencing Project, which will sequence the genetic code of everyone in UK BioBank to help develop novel and personalised forms of healthcare.

UK BioBank is globally unique in the depth and quality of the information that it contains about so many people in health and disease. Adding whole genome sequencing data to this will provide major opportunities to improve how we prevent, diagnose and treat the chronic conditions that afflict so many of us as we live longer lives.

John Lepore, Senior Vice President, Research at GlaxoSmithKline (GSK) said:

This historic whole genome sequencing effort is a welcome asset for researchers and testament to the volunteers who believe in the power of data to advance science.

Genetically validated drug candidates are twice as likely to become registered novel medicines, and efforts like this bring us closer to developing transformational medicines that can significantly improve patient health and change lives.

Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, commented:

Whole genome sequencing on this scale is unprecedented, and through this collaboration we hope to unlock the potential of genomics to evolve our understanding of complex diseases such as cancer, heart disease and chronic kidney disease.

These new insights will guide our drug discovery programme and will help us bring innovative new precision medicines to patients who need them most urgently.

Richard Tillyer, PhD, Global Head, Janssen Discovery, Johnson & Johnson, commented:

We are proud to participate in this ground-breaking initiative to generate genomics data from samples obtained through the generosity of citizens/people in the United Kingdom.

The insights gained from the analysis of this rich data set will guide our efforts to develop safe and effective therapies so that diseases aren’t just being treated, they are predicted, pre-empted and stopped in their tracks to help generations of people live their healthiest lives.

David M. Reese, M.D., Executive Vice-President of Research and Development at Amgen said:

We are pleased to partner on a project with immense potential to advance public health. This collaboration reflects our belief in the power of human genetics to transform medicine and the need for continued growth in the size and diversity of the data that can be mined for new discoveries for patients with serious life-threatening diseases.

Categories
BEIS

Press release: PM meets with small businesses

The Prime Minister and Business Secretary Andrea Leadsom met with small businesses today in Downing Street to discuss how best to help them start and grow.

The Prime Minister welcomed small business owners and entrepreneurs from a range of sectors across the UK, including tech, retail and manufacturing. As small businesses are the country’s biggest employers, he also welcomed this morning’s figures that show employment at a record high and wages are continuing to rise.

He outlined that he wants to build a dynamic, vibrant culture for start-ups, small businesses and entrepreneurs in the UK, which means bringing gigabit broadband speeds to everyone and creating a tax environment that stimulates growth. The PM and Business Secretary heard about other areas to boost the growth and productivity of small enterprises, such as tackling late payments, providing export opportunities and improving the skills and education of young people starting out in business.

On Brexit, the Prime Minister emphasised that he wants the UK to leave the EU with a deal and that we are working hard to get one, but that this will require movement from the EU. The Business Secretary also highlighted her recent meeting banking chiefs to launch the new Business Finance Council and encourage support for SMEs, both as we leave the EU and beyond.

They thanked all for constructive discussions and committed to continue to work with small businesses to take forward the ideas discussed.

  • Andrew McRae, Museum Context
  • Anthony Impey, Optimity
  • Jenny Evans, Jenny Kate Ltd
  • Sue Terpilowski, Image line
  • Gareth Alexander, The Market Place
  • Emma Heathcote James, Little Soap Company
  • Liz Smith, LG Davis
  • Damini Sharma, The OM Group
  • Maria Whitehead, Hawkshead Relish
  • Gill Hall, Butler’s Cheeses
  • Jurga Zilinskiene, Guildhawk
  • Steve Oliver, Music Magpie
  • Henry de Zoete, Look After My Bills
  • Ben Francis, Hygrove Homes
  • Amar Qureshi, Agilia
  • Liana Wilson-Fricker, The Inspiration Space
  • Sally Pritchett, Something Big
  • Rohan Pradhan, Deliveroo
Categories
Gazprom

Anton Kamenskikh wins International Welding Competition in Manual Arc Welding category

September 10, 2019

With support from the International Institute of Welding, the 2019 Arc Cup International Welding Competition took place in Langfang, China. The competition involved more than 300 professionals from 10 countries. The Russian Federation was represented by a team of 19 welders who had won awards and prizes at industry competitions. Among the participants was Anton Kamenskikh from Gazprom Transgaz Tchaikovsky.

The Russian team won first place in the medal standings. The champion title in the most prestigious category – Manual Arc Welding – went to Anton Kamenskikh.

Background

Anton Kamenskikh is employed as an electric and gas welder at the Permskoye Gas Pipeline Operation Center of Gazprom Transgaz Tchaikovsky (a wholly-owned subsidiary of Gazprom). In 2017, he took first place in the Best Welder professional excellence contest at the labor festival of Gazprom Transgaz Tchaikovsky.

Categories
BEIS

Detailed guide: Smart Meter Enabled Thermal Efficiency Ratings (SMETER) Innovation Programme

This funding scheme is to develop, test and demonstrate technologies that measure the thermal performance of homes using smart meter and other data. These have been termed Smart Meter Enabled Thermal Efficiency Ratings (SMETER).

SMETER Innovation Competetion: Phase 2

SMETER Innovation Competition: Phase 2 is for SMETER products which are already at a commercial stage of development. It does not provide further funding for development.

Applicants should have products that are ready to take part (together with the previously funded SMETER products) in the Phase 2 field trials to demonstrate their performance.

BEIS is providing support through funding for an expert contractor to run the field trials and evaluate the different SMETER technologies.

Any published results will be anonymised.

SMETER Innovation Competition

Up to £4.1 million was provided for innovation projects to develop SMETER tools. Up to £900,000 was provided for a Technical Assessment Contractor to independently test and demonstrate SMETER tools developed during the innovation projects:

Successful projects from Phase 1

The 8 projects which have secured funding in this competition are:

  • Building Research Establishment
  • EDF
  • Hoare Lea LLP
  • Centre for Sustainable Energy
  • PassivSystems
  • Build Test Solution
  • Switchee
  • CAR

The contract for Technical Assessment Contractor was awarded to a consortium made up of:

  • Loughborough University
  • UCL
  • Leeds Beckett
  • Halton Housing

Find out more

For more information, please email BuiltEnvironmentInnovation@beis.gov.uk.

Categories
BEIS

News story: Over £500m new investment in green technologies for a cleaner and healthier future

  • £400 million fund to help develop rapid charging infrastructure points for electric vehicles
  • First £70 million investment will create 3,000 new rapid charge points, more than doubling the number of rapid charge points across the UK by 2024
  • Further £142.9m announced for R&D to combat air and water pollution, and increase sustainability to support Government’s ambitious commitment to tackling climate change

Plans for a cleaner and healthier Britain stepped up a gear today, as Ministers announced more than half a billion pounds of investment in green technologies.

The Treasury has launched a £400 million fund to bolster Britain’s electric vehicle charging infrastructure, with the first £70 million allocated for 3000 charge points – more than doubling the number across the UK to 5000.

Rapid charge points can recharge a family car in as little as 20 minutes, compared to existing technology which can take 40 minutes- making the reality of driving electric vehicles easier and more accessible for people across the country. The UK already has one of the largest electric vehicle charging networks in Europe, and this investment will help make that the fastest by installing state-of-the-art technology.

A review is currently underway to explore the provision of charge points across major road networks, meaning drivers could charge their car whilst stopping for a coffee at a service station. Today’s investment complements £1.5 billion support to boost the uptake of electric vehicles and make cleaner vehicles more accessible to everyone. This is part of the Government’s ambition to end the sale of petrol and diesel vehicles by 2040.

Also being announced today is £31.5 million for research into pioneering technologies to remove greenhouse gases from the atmosphere, and £22 million to research new kinds of air pollutants and minimise their effects on public health.

Exchequer Secretary Simon Clarke said:

We are driving ahead with plans to make travel greener while backing British innovation and technology.

I am delighted to announce this funding today that will more than double the number of rapid charge points for electric vehicles on our roads. Britain already boasts one of the biggest networks of charging infrastructure in Europe and soon we will have the fastest thanks to this investment.

This is the latest in our proud record on climate change –having slashed emissions by over 40% since 1990, whilst simultaneously growing our economy, and setting an ambitious target for net zero emissions by 2050.

Business, Energy and Clean Growth Minister Kwasi Kwarteng said:

The UK has been going further and faster in tackling climate change by becoming the first major economy to legislate for net zero emissions by 2050 and helping us seize the opportunities of a greener future. With air pollution thought to kill as many as seven million people a year globally, it’s clear more needs to be done.

That’s why we’re backing these initiatives, aimed at making improvements from battling air pollutants to protecting our invaluable sea life. These pioneering projects will help us maintain our world-leading position in this field, and to make further strides towards a more sustainable future for our planet.

Transport Secretary Grant Shapps said:

It’s fantastic there is already a rapid chargepoint at almost every motorway service station, and now more charging stations than petrol stations. But I want to see thousands more chargepoints installed across the UK.

This fund will help drum up further investment in charging infrastructure from the private sector, so charging an electric car becomes as easy as plugging in a smart phone.

Further investment into green technology being announced today

The Department for Business, Energy and Industrial Strategy has today taken another vital step in cleaning up the planet by unveiling £142.9 million investment in green projects, including driving forward approaches to removing greenhouse gases from the air. Part of the second wave of the Government’s Strategic Priority Fund, the investment boost is evidence of the Government’s steadfast commitment to ensure a healthy, happy planet and population.

Five projects are benefiting from the significant cash injection, including:

  • Greenhouse Gas Removal Technologies (£31.52m) – this will support the UK in its net zero ambitions, by driving forward approaches to remove greenhouse gases from the sky on a large scale

  • Clean Air: Addressing the Challenge of Indoor & Outdoor Pollution (£22m) – the next decade will see declining transport pollution but increases in other areas like household products and adhesives. This project will look at tackling emerging air pollutants indoors and outdoors, such as air fresheners and cleaning products, to minimise their effects on public health

  • Cleaner food systems for healthy people and a healthy planet (£47 million) –– this will transform UK diets to be healthier and more sustainable through changes in production, manufacturing, retail and consumption. It will deliver coherent evidence to enable concerted action from policy, business and civil society to help the UK meet its targets on obesity and greenhouse gas emissions.

  • Reusing and recycling materials in innovative ways (£30 million) – this programme will drive forward new research to support opportunities to re-use and recycle materials across sectors such as food, water, textiles and electronics – as well accelerating new, greener manufacturing technologies

  • Sustainable Management of Marine Resources (£12.43m) – This programme will ensure that the UK realises sustainable societal and economic benefits through better management of the UK’s marine resources, including working more closely with government, industry and the public.

Today’s announcements show the Government’s firm commitment to tackling climate change and to meeting its environmental responsibilities. As a world leader in clean growth, and the first major economy in the world to legislate to end its contribution to global warming by 2050, today’s announcements echo the UK’s commitment to being in the driving seat of the green revolution.

Further Information

  • The Charging Infrastructure Investment Fund will be managed and invested on a commercial basis by private sector partners, and government will invest up to £200m to be matched by private investors.

  • The fund is leveraging private investment to support the rollout of charge points for electric vehicles across the UK. The initial £70m investment has been provided by government and Masdar.

About the Strategic Priorities Fund:

  • The Strategic Priorities Fund supports high quality research and development priorities. This is the second wave of funding. The SPF Wave 2 total programme funding figure is £496.8 million. The fund is being delivered by UK Research and Innovation (UKRI).

More details about the funded projects can be found below:

1.Clean Air: Future Challenges (NERC) 

Natural Environment Research Council (NERC) and Met Office with Innovate UK, Economic and Social Research Council (ESRC), Engineering and Physical Sciences Research Council (EPSRC), Medical Research Council (MRC), Science and Technology Facilities Council (STFC), National Physical Laboratory (NPL), Department for Environment, Food and Rural Affairs (Defra), Department for Transport (DfT), Department for Health and Social Care (DHSC), Scottish Government and Welsh Government.

Funding requested: £22 million over 6 years

2.Greenhouse Gas Removal Demonstrators (NERC) 

NERC with Arts and Humanities Research Council (AHRC), Biotechnology and Biological Science Research Council (BBSRC), ESRC, EPSRC, Innovate UK, Department for Business Energy and Industrial Strategy (BEIS), Defra and Ministry of Housing, Communities and Local Government (MHCLG)

Funding requested: £31.52 million over 5 years

3.Sustainable Management of UK Marine Resources (NERC) 

NERC with ESRC, Defra and Scottish Government. 

Funding requested: £12.43 million over 4 years 

4.A food systems approach for healthy people and a healthy planet (BBSRC) 

BBSRC with Medical Research Council, NERC, Defra, DHSC and Food Standards Agency  

Funding requested: £47 million over 6 years. Defra will contribute an additional £500k over 6 years  

5.National interdisciplinary Circular Economy Research Programme (EPSRC) 

EPSRC, with NERC, AHRC, Defra and BEIS

Funding requested: £30 million over 5 years 

Categories
BEIS

National Statistics: Road fuel prices: 9 September 2019